• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach.

作者信息

Giunchi Valentina, Fusaroli Michele, Hauben Manfred, Raschi Emanuel, Poluzzi Elisabetta

机构信息

Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Pfizer Inc, New York, NY, USA.

出版信息

Drug Saf. 2023 Oct;46(10):921-926. doi: 10.1007/s40264-023-01345-w. Epub 2023 Aug 31.

DOI:10.1007/s40264-023-01345-w
PMID:37651086
Abstract
摘要

相似文献

1
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach.获取和分析药品不良反应事件报告系统(FAERS)数据的挑战与机遇:呼吁采用协作方法
Drug Saf. 2023 Oct;46(10):921-926. doi: 10.1007/s40264-023-01345-w. Epub 2023 Aug 31.
2
Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.利用社交媒体报告药物不良反应来补充美国食品和药物管理局不良事件报告系统:比较分析。
JMIR Public Health Surveill. 2020 Sep 30;6(3):e19266. doi: 10.2196/19266.
3
[Analysis of Information on Drug Adverse Reactions Using U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)].[使用美国食品药品监督管理局不良事件报告系统(FAERS)对药物不良反应信息进行分析]
Yakugaku Zasshi. 2022;142(4):341-344. doi: 10.1248/yakushi.21-00178-5.
4
The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.韦伯效应与美国食品药品监督管理局不良事件报告系统(FAERS):对2006年至2010年批准的62种药物的分析
Drug Saf. 2014 Apr;37(4):283-94. doi: 10.1007/s40264-014-0150-2.
5
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.含红曲米的膳食补充剂的不良事件:FAERS 和 CAERS 报告系统的比较分析。
Drug Saf. 2018 Aug;41(8):745-752. doi: 10.1007/s40264-018-0661-3.
6
Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.药物相关性急性肾损伤在美国食品和药物管理局不良事件报告系统数据库中的识别。
Pharmacotherapy. 2018 Aug;38(8):785-793. doi: 10.1002/phar.2152. Epub 2018 Jul 13.
7
Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS).激励报告:美国食品药品监督管理局发布的警报对不良事件报告系统(FAERS)的影响。
Drug Saf. 2014 Nov;37(11):971-80. doi: 10.1007/s40264-014-0225-0.
8
Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS).在美国食品药品监督管理局不良事件报告系统(FAERS)中观察到,使用司库奇尤单抗后脑血管意外报告有所增加。
Br J Dermatol. 2023 May 24;188(6):793-794. doi: 10.1093/bjd/ljad039.
9
Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.在 FDA 不良事件报告系统 (FAERS) 数据库中分析药物性肝损伤的累积比例报告比值。
Drug Saf. 2013 Dec;36(12):1169-78. doi: 10.1007/s40264-013-0116-9.
10
Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).美国食品和药物管理局不良事件报告系统(FAERS)中的颌骨骨坏死。
J Bone Miner Res. 2016 Feb;31(2):336-40. doi: 10.1002/jbmr.2693. Epub 2015 Sep 4.

引用本文的文献

1
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) Codes.蒜泥蛋黄酱:将美国食品药品监督管理局不良事件报告系统(FAERS)中的药品标准化为RxNorm和解剖学治疗学化学(ATC)代码。
Pharmacoepidemiol Drug Saf. 2025 Sep;34(9):e70216. doi: 10.1002/pds.70216.
2
Remimazolam's clinical application and safety: A signal detection analysis based on FAERS data and literature support.瑞马唑仑的临床应用与安全性:基于FAERS数据和文献支持的信号检测分析
PLoS One. 2025 Aug 22;20(8):e0330769. doi: 10.1371/journal.pone.0330769. eCollection 2025.
3
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014-2023).

本文引用的文献

1
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching.通过文献参考归一化和模糊字符串匹配检测到 FDA 不良事件报告系统中更极端的重复。
Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):387-391. doi: 10.1002/pds.5555. Epub 2022 Dec 9.
2
A Standardized Dataset of a Spontaneous Adverse Event Reporting System.一个自发不良事件报告系统的标准化数据集。
Healthcare (Basel). 2022 Feb 23;10(3):420. doi: 10.3390/healthcare10030420.
3
The challenges of big data biology.大数据生物学面临的挑战。
BRAF和MEK抑制剂在黑色素瘤中的心血管安全性概况:通过回顾性不成比例分析的FAERS数据(2014 - 2023年)
Cancers (Basel). 2025 May 23;17(11):1755. doi: 10.3390/cancers17111755.
4
FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS.美国食品药品监督管理局不良事件报告系统(FAERS)要点:解读、应用及阐释向FAERS报告的不良事件数据指南
Clin Pharmacol Ther. 2025 Sep;118(3):567-582. doi: 10.1002/cpt.3701. Epub 2025 May 19.
5
Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance.抗淀粉样蛋白单克隆抗体lecanemab的长期监测:药物警戒的权利与义务
Alzheimers Res Ther. 2025 Apr 11;17(1):80. doi: 10.1186/s13195-025-01699-6.
6
Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis.药物相关性牙龈疾病:一项使用不成比例分析的回顾性药物警戒评估
BDJ Open. 2025 Mar 11;11(1):24. doi: 10.1038/s41405-024-00291-8.
7
Adverse events in the nervous system associated with blinatumomab: a real-world study.与博纳吐单抗相关的神经系统不良事件:一项真实世界研究。
BMC Med. 2025 Feb 6;23(1):72. doi: 10.1186/s12916-025-03913-6.
8
Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.药物性尿潴留:一项使用美国食品药品监督管理局(FDA)和加拿大药物警戒数据库的真实世界药物警戒研究。
Front Pharmacol. 2025 Jan 6;15:1466875. doi: 10.3389/fphar.2024.1466875. eCollection 2024.
9
Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database.右丙亚胺与蒽环类药物联合使用的安全性评估:基于美国食品药品监督管理局不良事件报告系统数据库的不成比例性分析
Pharmaceuticals (Basel). 2024 Dec 23;17(12):1739. doi: 10.3390/ph17121739.
10
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline.药物警戒中不成比例性分析的报告:聚焦于READUS-PV指南。
Front Pharmacol. 2024 Nov 27;15:1488725. doi: 10.3389/fphar.2024.1488725. eCollection 2024.
Elife. 2019 Apr 5;8:e47381. doi: 10.7554/eLife.47381.
4
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.利用不良事件报告数据挖掘与药物治疗方案相关的不同临床结果。
Nat Biotechnol. 2016 Jul 12;34(7):697-700. doi: 10.1038/nbt.3623.
5
OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.OpenVigil美国食品药品监督管理局——美国药品不良事件药物警戒数据及新型临床应用检查
PLoS One. 2016 Jun 21;11(6):e0157753. doi: 10.1371/journal.pone.0157753. eCollection 2016.
6
A curated and standardized adverse drug event resource to accelerate drug safety research.一个经过策划和标准化的药物不良事件资源,以加速药物安全研究。
Sci Data. 2016 May 10;3:160026. doi: 10.1038/sdata.2016.26.
7
AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.AERS蜘蛛:一种用于挖掘不良事件报告系统中统计关联的在线交互式工具。
Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):795-801. doi: 10.1002/pds.3561. Epub 2014 Feb 12.
8
OpenVigil--free eyeballs on AERS pharmacovigilance data.OpenVigil——关注药品不良反应事件报告系统(AERS)药物警戒数据的免费工具。
Nat Biotechnol. 2012 Feb 8;30(2):137-8. doi: 10.1038/nbt.2113.
9
Paradoxical and bidirectional drug effects.矛盾和双向药物效应。
Drug Saf. 2012 Mar 1;35(3):173-89. doi: 10.2165/11597710-000000000-00000.
10
'Extreme duplication' in the US FDA Adverse Events Reporting System database.美国食品药品监督管理局不良事件报告系统数据库中的“极度重复”现象。
Drug Saf. 2007;30(6):551-4. doi: 10.2165/00002018-200730060-00009.